Short-Term Oral Sorafenib for Therapy of Intratumoral Shunts of Hepatocellular Carcinoma to Enable Intraarterial Treatment

ConclusionEven short-term oral sorafenib seems to effectively close intratumoral shunts in patients with HCC and thus might enable transarterial treatment of these patients.

http://link.springer.com/10.1007/s00270-019-02294-7

Source: CardioVascular and Interventional Radiology - August 30, 2019 Category: Radiology Source Type: research